Clinical Trial Update: Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1) [Phase 2, Phase 3]

View source ↗

Summary

A completed trial update for PRAX-628 in adults with focal seizures across Phase 2/Phase 3 testing focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Seizure

Drugs mentioned

• PRAX-628

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Focal Seizure | Phase 2, Phase 3 | Status: COMPLETED